’21 Earnings Hang on Medicare Risk Adjustment Uncertainties

Although growing Medicare Advantage enrollment helped fuel better-than-expected first-quarter 2021 earnings for some publicly traded insurers, they appear to be approaching the full year with caution, as earnings in 2021 could be dampened by a couple of factors. These include the unfavorable impact of the health insurer fee (HIF) repeal for 2021 and lower Medicare risk-adjusted revenue — a recurring and expected theme during insurers’ recent quarterly earnings calls.

Risk scores that determine MA organizations’ risk adjustment payments for the current year are based on diagnoses gathered during the previous year to determine the relative health of an insurer’s MA enrollees and predict costs. But because the pandemic led many seniors to delay or forgo care, insurers’ ability to collect diagnoses last year was limited, despite the temporary authorization to use telehealth to gather diagnoses for MA risk adjustment.

© 2024 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

Related Posts

clover-health
June 20

Insurtech Investor Talks Highlight Promise of MA Despite Headwinds

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
June 20

News Briefs: Lawmakers Take Another Stab at Improving Prior Authorization in MA

READ MORE
patient-access-transportation
June 20

Elevance Research Touts Supplemental Benefits’ Impact on Utilization

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today